effect overlay
activetrials

Improving early reperfusion with adjuvant dornase alfa in large vessel ischemic stroke
 

HREC: 2021.316
Principal Investigator: Prof Bruce Campbell
Coordinator contact: Amy McDonald
Funding: Non-Commercial
Stroke

M19-148: A Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic Stroke
 

HREC: 2022.110
Principal Investigator: Prof Bruce Campbell
Coordinator contact: Amy McDonald
Funding: Commercial
Stroke

Colchicine After Stroke to Prevent Event Recurrence (CASPER)
 

HREC: 2022.202
Principal Investigator: Prof Bruce Campbell
Coordinator contact: David Jackson
Funding: Non-Commercial
Stroke

3-Stage, Multi-Centre, EMVision CP2/Gen 1 BrainScanner to Collect Data for Hardware Verification and Software Development for Imaging Acute Stroke from Healthy Participants and Participants Presenting with Stroke Symptoms to the Emergency Department
 

HREC: 2022.303
Principal Investigator: Dr Angela Dos Santos
Coordinator contact: Dr Anna Balabanski
Funding: Commercial
Stroke

Expanding Stroke therapy access, Stroke in patients with Large ishemic core
 

HREC: 2022.322
Principal Investigator: Prof Bruce Campbell
Coordinator contact:
Funding: Non-Commercial